VC Views - Category - VC Views - BioVox - Life sciences Breakthroughs

Join our 20.000 subscribers and receive the monthly newsletter for free!

Cultured meat, plant-based patties and bug burgers: VCs are backing protein alternatives

Written by Guest Author on Tuesday 16 April 2019 in the category VC Views with the tags finance, food.

When it comes to food, our key sources of nutrition haven’t changed much in the last ten thousand years. Though hyped-up food trends and diets come and go, our ancestors established the status quo…

Closing the gender gap in biotech funding

Written by Guest Author on Tuesday 19 March 2019 in the category VC Views with the tags finance, vision / opinion / people, vc views.

Companies with a good gender balance consistently outperform those with only men in their management teams. Yet despite this, start-ups with female founders and management team members are consist…

Life after a PhD: alternatives to academia

Written by Guest Author on Tuesday 19 February 2019 in the category VC Views with the tags academia, vision / opinion / people, vc views.

Having finished a PhD in life sciences can often leave you wondering: what’s next? The classic question is often “academia or industry?”, with a lot of preconceptions made about both career paths.…

Are we spending too much money on cancer drugs?

Written by Guest Author on Tuesday 22 January 2019 in the category VC Views with the tags cancer, drug discovery, vc views.

November is classically the month where immunotherapy takes center stage, especially at the annual conference of the Society for Immunotherapy of Cancer (SITC, endearingly pronounced sitsie). Imm…

Why start-ups can become mega companies in the pharma sector

Written by ALB on Tuesday 20 November 2018 in the category VC Views with the tags finance, startup, vc views.

In a previous BioVox article, we analyzed the steps needed for a life sciences start-up to turn into a fully integrated, commercial stage biotech company. For this to happen, the hurdles that need…

Are tech investments under threat by anti-science sentiments?

Written by ALB on Tuesday 30 October 2018 in the category VC Views with the tags vision / opinion / people, regulatory, vc views.

In biotech, company creation is usually preceded by scientific discoveries presenting solutions to existing problems. Because of this, early stage VC investment is, at its core, a science-driven a…

Bringing clinical trials into the home

Written by ALB on Tuesday 2 October 2018 in the category VC Views with the tags drug discovery, clinical trials, vc views.

Lowering the costs of drug development is more important than ever; with the increasing pressure on drug pricing and billions in funding poured into small biotechs, competition is fierce. While th…

Forever young: the science of aging well

Written by ALB on Tuesday 28 August 2018 in the category VC Views with the tags vision / opinion / people, vc views.

“Is aging a disease?” For a long time, the answer to this question seemed obvious: aging is a natural thing that happens to all of us. It is an inevitable side-effect of growing older. However…

Biotechs and subsidies - a fraught relationship

Written by ALB on Monday 23 July 2018 in the category VC Views with the tags finance, vision / opinion / people, vc views.

The ambition of any CEO heading a biotech start-up is to develop a new product and to reach patients quickly. However, drug development comes with long development timelines, making Biotech a capi…

Acquisitions of Biotech companies: a good or a bad thing?

Written by DS on Monday 14 May 2018 in the category VC Views with the tags finance, vision / opinion / people, vc views.

When on the 8th January 2018 the news travelled that Novo Nordisk made a €2.6bn bid for Belgium’s Ablynx, only to be leapfrogged a few weeks later by the € 3.9bn Sanofi bid, we immediately picture…

UGent GSK Biowin Turnstone Flanders.bio Janssen KU Leuven Itera Life Science XpandInnovation V-Bio Ventures

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights.

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.

QUICK LINKS

INSIGHTS ARCHIVE

Read more…

BioVox - Life sciences Breakthroughs

Search

Cultured meat, plant-based patties and bug burgers: VCs are backing protein alternatives

Closing the gender gap in biotech funding

Life after a PhD: alternatives to academia

Are we spending too much money on cancer drugs?

Why start-ups can become mega companies in the pharma sector

Are tech investments under threat by anti-science sentiments?

Bringing clinical trials into the home

Forever young: the science of aging well

Biotechs and subsidies - a fraught relationship

Acquisitions of Biotech companies: a good or a bad thing?

ABOUT BIOVOX - Sharing Life Sciences Innovations

QUICK LINKS

INSIGHTS ARCHIVE

PARTNERS

Sign up to our Mailing List to receive updates of our latest News, Events & Magazines

ABOUT BIOVOX - Sharing Life Sciences Innovations

QUICK LINKS

INSIGHTS ARCHIVE

PARTNERS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines